Today we remember and support #WorldAIDSDay. Medical research has seen amazing advances and milestones over the past few decades. Here at IRBM, we are proud to have played a major role in the discovery of Raltegravir (Isentress) while part of Merck & Co, for the treatment of #HIV-1 infection in combination with other antiretroviral agents.
From October 19-21, ADVENT’s Qualified Person, Dr. Stefania di Marco, will attend the World Vaccine Congress Europe 2019 in Barcelona, Spain. She will be joined by Heidi Kingdon Jones, IRBM’s Global VP of Sales and Marketing. To learn more about the benefits of working with ADVENT, and about the facility, Please drop us a line to organize a meeting there.